CORC

在结果中检索

CORC

浏览/检索结果: 共370条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
PRELIMINARY MAGNETIC FIELD CALCULATION OF A 30-DEGREE DIPOLE MAGNET 会议论文
Australia, 2019
作者:  H. Liang;  J. Huang;  C. Jiang;  T. Liu;  B. Qin
收藏  |  浏览/下载：12/0  |  提交时间：2019/08/06
New Orbit Correction Method Based on SVDC Algorithm for Ring Based Light Sources 会议论文
Australia, 2019
作者:  X.Y. Huang;  J.S. Cao;  Y.Y. Du;  Y.H. Lu;  H.Z. Ma
收藏  |  浏览/下载：33/0  |  提交时间：2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Bedside Modified Volume-Viscosity Swallow Test Might be Reliably to Predict Risk of Aspiration Pneumonia After Stroke. 会议论文
作者:  Ye, Ting;  Huang, Sheng-Yan;  Dong, Yi;  Dong, Qiang
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Performance Evaluation Model for Numerical Calculation in GPU Environment 会议论文
作者:  Yin, Mengjia;  Huang, Weiming;  Xu, Xianbin;  Ye, Conghuan;  Zhang, Tao
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Research on optimization of active distribution network frame with improved particle swarm optimization algorithm 会议论文
作者:  Dai, Lei;  Ye, Bin;  Wang, Xuli;  Yin, Chenxu;  Zhao, Feng
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
An investigation of a nonlinear fuel oil viscosity and temperature control system for ships 会议论文
作者:  Ye, Zhuohang;  Mao, Xiaobing;  Huang, Hai;  Liu, Xianzhen
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace